184 related articles for article (PubMed ID: 32852763)
1. A Genetically Engineered Mouse Model of Malignant Testicular Germ Cell Tumors.
Lyndaker AM; Pierpont TM; Loehr AR; Weiss RS
Methods Mol Biol; 2021; 2195():147-165. PubMed ID: 32852763
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer.
Pierpont TM; Lyndaker AM; Anderson CM; Jin Q; Moore ES; Roden JL; Braxton A; Bagepalli L; Kataria N; Hu HZ; Garness J; Cook MS; Capel B; Schlafer DH; Southard T; Weiss RS
Cell Rep; 2017 Nov; 21(7):1896-1909. PubMed ID: 29141221
[TBL] [Abstract][Full Text] [Related]
3. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
[TBL] [Abstract][Full Text] [Related]
4. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
5. The chemosensitivity of testicular germ cell tumors.
Voutsadakis IA
Cell Oncol (Dordr); 2014 Apr; 37(2):79-94. PubMed ID: 24692098
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
[TBL] [Abstract][Full Text] [Related]
7. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
8. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.
Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A
BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous metastasis in mouse models of testicular germ-cell tumours.
Zechel JL; MacLennan GT; Heaney JD; Nadeau JH
Int J Androl; 2011 Aug; 34(4 Pt 2):e278-87. PubMed ID: 21651572
[TBL] [Abstract][Full Text] [Related]
10. Testicular germ cell tumor: a comprehensive review.
Batool A; Karimi N; Wu XN; Chen SR; Liu YX
Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
[TBL] [Abstract][Full Text] [Related]
11. Clonal analyses of refractory testicular germ cell tumors.
Barrett MT; Lenkiewicz E; Malasi S; Stanton M; Slack J; Andrews P; Pagliaro L; Bryce AH
PLoS One; 2019; 14(3):e0213815. PubMed ID: 30870501
[TBL] [Abstract][Full Text] [Related]
12. Will Testicular Germ Cell Tumors Remain Untargetable?
Aoun F; Kourie HR; Albisinni S; Roumeguère T
Target Oncol; 2016 Dec; 11(6):711-721. PubMed ID: 27184492
[TBL] [Abstract][Full Text] [Related]
13. The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo.
Jostes S; Nettersheim D; Fellermeyer M; Schneider S; Hafezi F; Honecker F; Schumacher V; Geyer M; Kristiansen G; Schorle H
J Cell Mol Med; 2017 Jul; 21(7):1300-1314. PubMed ID: 28026145
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
[TBL] [Abstract][Full Text] [Related]
15. Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.
Steinemann G; Dittmer A; Schmidt J; Josuttis D; Fähling M; Biersack B; Beindorff N; Jolante Koziolek E; Schobert R; Brenner W; Müller T; Nitzsche B; Höpfner M
Mol Oncol; 2019 Dec; 13(12):2679-2696. PubMed ID: 31583820
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
[TBL] [Abstract][Full Text] [Related]
17. Testicular germ cell tumors in mice: new ways to study a genetically complex trait.
Heaney JD; Nadeau JH
Methods Mol Biol; 2008; 450():211-31. PubMed ID: 18370062
[TBL] [Abstract][Full Text] [Related]
18. Tumors of the Testis: Morphologic Features and Molecular Alterations.
Howitt BE; Berney DM
Surg Pathol Clin; 2015 Dec; 8(4):687-716. PubMed ID: 26612222
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
20. Molecular and cell biology of testicular germ cell tumors.
Chieffi P; Franco R; Portella G
Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]